Month: April 2019

FDA Sends Stern Warning to Stem Cell Industry

Over the last several years the stem cell industry has broadened and shifted into areas of medicine that no one could have imagined a decade ago. In many instances, lives have been saved by cutting-edge technology and new innovations in the capabilities of stem cells to treat diseases that were historically deemed incurable. However, there is a drawback. Many of these practices have not been approved by the Food and Drug Administration and have led to irreversible damage in some patients.

Continue reading
Social media & sharing icons powered by UltimatelySocial
Facebook
Twitter
Pinterest